Ivetmar Medical Group, LLC

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Obstructive sleep apnoea2 trials
• Fatty liver disease (MASLD/MASH)1 trial
• Gout1 trial
• Schizophrenia1 trial

Phase

• Phase 35 trials
• Phase 21 trial

Status

• Completed5 trials
• Enrolling by invitation1 trial

Lead sponsor

• Apnimed2 trials
• Boehringer Ingelheim1 trial
• LG Chem1 trial
• Otsuka Pharmaceutical Development & Commercialization, Inc.1 trial
• Pfizer1 trial

Running trials

• Enrolling by invitation

  Continuation Protocol for Obstructive Sleep Apnea (OSA)

  NCT06566820· Phase 3· Apnimed· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obstructive sleep apnoea1 recruiting

Closed trials

• Completed

  Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)

  NCT05811247· Phase 3· Apnimed· Source

• Completed

  Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients

  NCT05586971· Phase 3· LG Chem· Source

• Completed

  A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder.

  NCT05279313· Phase 3· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source

• Completed

  CONNEX-3: A Study to Test Whether Iclepertin Improves Learning and Memory in People With Schizophrenia

  NCT04860830· Phase 3· Boehringer Ingelheim· Source

• Completed

  Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)

  NCT04321031· Phase 2· Pfizer· Source